Abiopharma

🔍 Qiu Wenbin (Director)

Company: Baozun Inc. (BZUN)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 11,000 shares of American Depositary Shares at $2.71 per share (Direct)
  Date: 2026-04-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,400,372.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 17,500 shares of American Depositary Shares at $2.84 per share (Direct)
  Date: 2026-04-16 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,417,872.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Represents a weighted-average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.71 to $2.72, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
• F2: Represents a weighted-average purchase price. These shares were purchased in multiple transactions at prices ranging from $2.839 to $2.840, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
• F3: Represents all American Depositary Shares held by JESFUND (SINGAPORE) PTE. LTD., a Singapore company wholly owned by the reporting person following the transaction(s) reported under this Form 4.